{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:53:49Z","timestamp":1782780829208,"version":"3.54.5"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.lfs.2020.118510","type":"journal-article","created":{"date-parts":[[2020,9,28]],"date-time":"2020-09-28T14:18:17Z","timestamp":1601302697000},"page":"118510","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["Pharmacological agents to therapeutic treatment of cardiac injury caused by Covid-19"],"prefix":"10.1016","volume":"262","author":[{"given":"A.","family":"Vitiello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Ferrara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2020.118510_bb0005","author":"John Hopkins University"},{"key":"10.1016\/j.lfs.2020.118510_bb0010","author":"Worl Health of Organization (WHO)"},{"key":"10.1016\/j.lfs.2020.118510_bb0015","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Peng","year":"2020","journal-title":"Nature"},{"issue":"21","key":"10.1016\/j.lfs.2020.118510_bb0020","doi-asserted-by":"crossref","first-page":"11727","DOI":"10.1073\/pnas.2003138117","article-title":"Cell entry mechanisms of SARS-CoV-2","volume":"117","author":"Jian","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2020.118510_bb0025","article-title":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China","author":"Ruan","year":"2020","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.lfs.2020.118510_bb0030","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Xu","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.lfs.2020.118510_bb0035","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2020.0950","article-title":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China","author":"Shi","year":"2020","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.lfs.2020.118510_bb0040","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2002032","article-title":"China medical treatment expert group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China","author":"Guan","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lfs.2020.118510_bb0045","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41569-020-0413-9","article-title":"COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives","volume":"17","author":"Nishiga","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.lfs.2020.118510_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(20)30257-7","article-title":"Likelihood of survival of coronavirus disease 2019","author":"Ruan","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.lfs.2020.118510_bb0055","first-page":"145","article-title":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China","volume":"41","author":"Epidemiology Working Group for NCIP Epidemic Response","year":"2020","journal-title":"Chin J Epidemiol"},{"key":"10.1016\/j.lfs.2020.118510_bb0060","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2020.1286","article-title":"Potential effects of coronaviruses on the cardiovascular system: a review","author":"Madjid","year":"2020","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.lfs.2020.118510_bb0065","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/S0140-6736(03)13412-5","article-title":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study","volume":"361","author":"Peiris","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2020.118510_bb0070","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41569-020-0360-5","article-title":"COVID-19 and the cardiovascular system","volume":"17","author":"Zheng","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.lfs.2020.118510_bb0075","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1093\/eurheartj\/ehm193","article-title":"Cardiac involvement in systemic inflammatory diseases","volume":"28","author":"Knockaert","year":"2007","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.lfs.2020.118510_bb0080","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/jth.14768","article-title":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia","volume":"18","author":"Tang","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.lfs.2020.118510_bb0085","doi-asserted-by":"crossref","first-page":"173373","DOI":"10.1016\/j.ejphar.2020.173373","article-title":"Correlation between renin-angiotensin system and severe acute respiratory syndrome coronavirus 2 infection: what do we know","volume":"883","author":"Vitiello","year":"2020","journal-title":"Eur. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.lfs.2020.118510_bb0090","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1093\/cvr\/cvaa106","article-title":"COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options","volume":"116","author":"Guzik","year":"2020","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.lfs.2020.118510_bb0095","doi-asserted-by":"crossref","first-page":"118400","DOI":"10.1016\/j.lfs.2020.118400","article-title":"Parameters predicting COVID-19-induced myocardial injury and mortality","volume":"260","author":"Duerr","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.lfs.2020.118510_bb0100","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2020.3551","article-title":"Association of cardiac infection with SARS-CoV-2 in confirmed COVID-19 autopsy cases","author":"Lindner","year":"2020","journal-title":"JAMA Cardiol."},{"issue":"5","key":"10.1016\/j.lfs.2020.118510_bb0105","doi-asserted-by":"crossref","first-page":"e010897","DOI":"10.1161\/CIRCIMAGING.120.010897","article-title":"Diffuse myocardial inflammation in COVID-19 associated myocarditis detected by multiparametric cardiac magnetic resonance imaging","volume":"13","author":"Luetkens","year":"2020","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.lfs.2020.118510_bb0110","first-page":"1","article-title":"The added value of pirfenidone to fight inflammation and fibrotic state induced by SARS-CoV-2: anti-inflammatory and anti-fibrotic therapy could solve the lung complications of the infection?","author":"Ferrara","year":"2020","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.lfs.2020.118510_bb0115","first-page":"1","article-title":"COVID-19 patients with pulmonary fibrotic tissue: clinical pharmacological rational of antifibrotic therapy","author":"Vitiello","year":"2020","journal-title":"SN Compr Clin Med"},{"key":"10.1016\/j.lfs.2020.118510_bb0120","article-title":"Cardiac involvement in patients recovered from COVID-2019 identified using magnetic resonance imaging","author":"Lu","year":"2020","journal-title":"J. Am. Coll. Cardiol. Img."},{"key":"10.1016\/j.lfs.2020.118510_bb0125","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nrcardio.2014.59","article-title":"Angiotensin-converting enzyme 2 and angiotensin 1\u20137: novel therapeutic targets","volume":"11","author":"Jiang","year":"2014","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.lfs.2020.118510_bb0130","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jacc.2010.02.047","article-title":"Assessment of nonischemic myocardial fi- brosis","volume":"56","author":"Jellis","year":"2010","journal-title":"J. Am. Col. Cardiol."},{"key":"10.1016\/j.lfs.2020.118510_bb0135","doi-asserted-by":"crossref","unstructured":"Tan WSD, Liao W, Zhou S, Mei D, Wong WF. Targeting the renin-angiotensin system as novel therapeutic strategy for pulmonary diseases. CurrOpinPharmacol. 201; 40: 9\u201317. doi:https:\/\/doi.org\/10.1016\/j.coph.2017.12.002. (Epub 2017 Dec 27).","DOI":"10.1016\/j.coph.2017.12.002"},{"key":"10.1016\/j.lfs.2020.118510_bb0140","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1161\/01.CIR.0000081768.13378.BF","article-title":"Activation and functional significance of therenin-angiotensin system in mice with cardiac restricted overexpression of tumor necrosis factor","volume":"108","author":"Flesch","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.lfs.2020.118510_bb0145","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cardiores.2005.01.011","article-title":"Healing after myocardial infarction","volume":"66","author":"Ertl","year":"2005","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.lfs.2020.118510_bb0150","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ijcard.2016.12.029","article-title":"Aldosterone pathway blockade to prevent atrial fibrilla- tion: a systematic review and meta-analysis","volume":"231","author":"Neefs","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.lfs.2020.118510_bb0155","article-title":"Sacubitril valsartan and SARS-CoV-2","author":"Vitiello","year":"2020","journal-title":"BMJ Evidence-Based Medicine"},{"key":"10.1016\/j.lfs.2020.118510_bb0160","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.bbrc.2007.02.085","article-title":"CNP infusion attenuates cardiac dysfunction and inflammation in myocarditis","volume":"356","author":"Obata","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2020.118510_bb0165","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.jacc.2004.10.067","article-title":"C-type natriuretic peptide, a novel antifibrotic and antihypertrophic agent, prevents cardiac remodeling after myocardial infarction","volume":"45","author":"Soeki","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.lfs.2020.118510_bb0170","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/art.38199","article-title":"Protective effects of C-type natriuretic peptide on linear growth and articular cartilage integrity in a mouse model of inflammatory arthritis","volume":"66","author":"Bukulmez","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.lfs.2020.118510_bb0175","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s40290-020-00342-z","article-title":"IL-6 inhibitors in the treatment of serious COVID-19: a promising therapy?","volume":"34","author":"Atal","year":"2020","journal-title":"Pharm Med"},{"key":"10.1016\/j.lfs.2020.118510_bb0180","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.lfs.2020.118510_bb0185","first-page":"88","article-title":"Cytokine storm and colchicine potential role in fighting SARS-CoV-2 pneumonia","volume":"14","author":"Vitiello","year":"2020","journal-title":"Italian Journal of Medicine"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320520312637?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320520312637?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:34:50Z","timestamp":1758400490000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320520312637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":37,"alternative-id":["S0024320520312637"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2020.118510","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological agents to therapeutic treatment of cardiac injury caused by Covid-19","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2020.118510","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"118510"}}